San Diego-headquartered Illumina, a leader in DNA sequencing and array-based technologies, said it will establish a Global Capability Center (GCC) in Bengaluru as part of its plans to expand the ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

This regulation is facilitated by a short fragment within the miRNA, which can bind to the target mRNA molecule if it finds a reverse complement (biologically compatible) sequence. When this ...

After hours: September 27 at 4:45 PM EDT ...

Illumina Inc., a key player in DNA sequencing and array-based technologies, on Friday that it will establish a Global Capability Center in Bengaluru, India, as an investment to expand its ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ ... fine that the U.S. gene sequencing company had to pay. However, the ruling ...

The legal vindication arrives too late for Illumina, the U.S. gene-sequencing powerhouse, which spun off Grail as a stand-alone public company this summer to comply with government orders.